Yu Oyama
ORCID:0000-0001-6440-8310
发表论文 83 篇 · 总被引 1039 次 · h-index 17
代表论文
- Effectiveness of pembrolizumab in patients with urothelial carcinoma receiving proton pump inhibitors (2022 · Urologic Oncology Seminars and Original Investigations · 被引 24)
- Effectiveness of pembrolizumab in trial-ineligible patients with metastatic urothelial carcinoma (2022 · Cancer Immunology Immunotherapy · 被引 5)
- Psychological barriers to the use of opioid analgesics for treating pain in patients with advanced recurrent cancer (BAROC): protocol for a multicentre cohort study (2022 · BMJ Open · 被引 3)
- Association between comorbidities and survival in patients with metastatic urothelial carcinoma treated with pembrolizumab (2024 · International Journal of Clinical Oncology · 被引 2)
- Combination Therapy of Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel for Metastatic Non-squamous Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor Resistance and EGFR Mutations (2024 · Cureus · 被引 1)
- Anti-asparaginyl-tRNA synthetase antibody-positive pneumonitis in a patient with immune checkpoint inhibitor treatment: A case report and literature review (2024 · Modern Rheumatology Case Reports · 被引 1)